172 related articles for article (PubMed ID: 4566189)
1. Alterations of cell surfaces as a pathogenetic factor in psoriasis. Possible loss of contact inhibition of growth.
Orfanos CE; Schaumburg-Lever G; Mahrle G; Lever WF
Arch Dermatol; 1973 Jan; 107(1):38-46. PubMed ID: 4566189
[No Abstract] [Full Text] [Related]
2. Studies on the ultrastructure of psoriasis and of the "normal" skin of psoriatics.
Nagy-Vezekényi C; Zs-Nagy I
Acta Derm Venereol; 1971; 51(6):435-43. PubMed ID: 4109424
[No Abstract] [Full Text] [Related]
3. Metabolic and ultrastructural studies in a patient with pustular psoriasis (von Zumbusch).
Braverman IM; Cohen I; O'Keefe E
Arch Dermatol; 1972 Feb; 105(2):189-96. PubMed ID: 4334267
[No Abstract] [Full Text] [Related]
4. [Psoriasis].
Guilhou JJ; Girard C
Rev Prat; 2006 Dec; 56(19):2153-8. PubMed ID: 17416055
[No Abstract] [Full Text] [Related]
5. Psoriasis: current concepts in management.
Hodge L; Comaish JS
Drugs; 1977 Apr; 13(4):288-96. PubMed ID: 324749
[TBL] [Abstract][Full Text] [Related]
6. Aspects of the Odland bodies in the synthesis of keratohyalin.
Lagerholm B; Frithz A
Acta Derm Venereol; 1974; 54(5):359-64. PubMed ID: 4138189
[No Abstract] [Full Text] [Related]
7. The action of antimetabolites in the skin: methotrexate for psoriasis.
Weinstein GD
Adv Biol Skin; 1972; 12():287-302. PubMed ID: 4579196
[No Abstract] [Full Text] [Related]
8. Biochemical and pathophysiological rationale for amethopterin in psoriasis.
Weinstein GD
Ann N Y Acad Sci; 1971 Nov; 186():452-66. PubMed ID: 5289429
[No Abstract] [Full Text] [Related]
9. Ultrastructural findings and tumor necrosis factor-alpha and intercellular adhesion molecule-1 expression in psoriasis patients before and after oral cyclosporin A therapy.
Eşrefoğlu M; Gül M; Seyhan M
Ultrastruct Pathol; 2006; 30(1):95-102. PubMed ID: 16517475
[TBL] [Abstract][Full Text] [Related]
10. Psoriasis-liver-methotrexate interactions.
Arch Dermatol; 1973 Jul; 108(1):36-42. PubMed ID: 4716740
[No Abstract] [Full Text] [Related]
11. [Membrane defect as a basic disorder of the growth control mechanism in psoriasis pathogenetic concept and therapeutic consequences (author's transl)].
Orfanos CE; Mahrle G
Dermatologica; 1975; 151(4):199-215. PubMed ID: 178549
[TBL] [Abstract][Full Text] [Related]
12. The nature of psoriasis.
Fry L
Br J Dermatol; 1968 Dec; 80(12):833-5. PubMed ID: 5706801
[No Abstract] [Full Text] [Related]
13. Chromosome aberrations in affected and unaffected skin of patients with psoriasis.
Petersen GB; Christiansen JV; Voetmann E; Therkelsen AJ
Acta Derm Venereol; 1974; 54(2):147-51. PubMed ID: 4133021
[No Abstract] [Full Text] [Related]
14. Primary annular plaque-type psoriasis.
Guill CL; Hoang MP; Carder KR
Pediatr Dermatol; 2005; 22(1):15-8. PubMed ID: 15660890
[TBL] [Abstract][Full Text] [Related]
15. Effects of methotrexate and hydroxyurea on psoriatic epidermis. Preferential cytotoxic effects on psoriatic epidermis.
Smith C; Gelfant S
Arch Dermatol; 1974 Jul; 110(1):70-2. PubMed ID: 4418706
[No Abstract] [Full Text] [Related]
16. Biological and biochemical actions of methotrexate in psoriasis.
Newburger AE; Weinstein GD; McCullough JL
J Invest Dermatol; 1978 Apr; 70(4):183-6. PubMed ID: 641369
[No Abstract] [Full Text] [Related]
17. Cell proliferation kinetics in benign and malignant skin diseases in humans.
Weinstein GD; Frost P
Natl Cancer Inst Monogr; 1969 May; 30():225-46. PubMed ID: 5361648
[No Abstract] [Full Text] [Related]
18. Cellular changes in psoriatic and normal epidermis after treatment with ammonium mercuric chloride. Electron microscopy, tissue culture and neutron activation analyses.
Frithz A
Acta Derm Venereol Suppl (Stockh); 1971; 51():Suppl 66:1-20. PubMed ID: 5284815
[No Abstract] [Full Text] [Related]
19. [Immunosuppressive drugs in the treatment of diseases belonging to the psoriasis group].
Ruszczak Z
Pol Tyg Lek; 1974 Jun; 29(24):1051-3. PubMed ID: 4602505
[No Abstract] [Full Text] [Related]
20. [Comparative study of the effect of the antimetabolic agent methotrexate in psoriasis, psoriatic arthropathy and rheumatoid arthritis].
Siegmeth W; Eberl R; Tausch G; Raith W
Verh Dtsch Ges Rheumatol; 1969; 1():383-7. PubMed ID: 5403653
[No Abstract] [Full Text] [Related]
[Next] [New Search]
